Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LMRI will - over the next 2 Weeks and hit - by . In that time frame, LMRI's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
LMRI shares rose +5.65% in Wednesday, May 6, 2026's trading session, rising from a previous close of $9.73 to move at $10.28. The stock demonstrated notable intraday movement (see LMRI's key stats for a full breakdown), fluctuating between $9.61 and $10.47, a +8.95% trading range. While recent weeks have seen some volatility, LMRI has managed to secure a +10.30% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 474.97K shares changing hands, 214.06K fewer than the previous session. This amounted to $4.88M in total market activity.
Will LMRI Continue Its Trend?
According to analyst ratings and projections for LMRI, Lumexa Imaging Holdings, Inc. Common Stock shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for LMRI. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the LMRI stock forecast, now is not the best time to buy LMRI stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on LMRI covering social and institutional perspectives.
LMRI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LMRI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.81% to 60.11%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 42.49%, suggests a neutral medium-term outlook. Insights into LMRI's shareholder base show how institutional investors are positioning themselves during these momentum shifts

